ABCL
AbCellera Biologics Inc. · Healthcare
Director Michael R Hayden bought $1.5M of AbCellera Biologics Inc.
Bought$1,473,300
$20.00Price
73,665Shares
+6%Stake
What ABCL did for a copier
- $1,000 copied at Thu, Dec 17 close, $48.60
- $987
- S&P 500, same days
- +2.9%
Measured over 30 trading days, to the Feb 2 close.
Michael R Hayden's record
4 other buys with 3 months of prices since 2017: on average −4.1% against the S&P 500, and 2 of 4 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Dec 15. Filed Thu, Dec 17, 3:30 PM ET, during the session. Returns use the Dec 17 close and the Feb 2 close. Not investment advice.